George C Eckert Ii
Examiner (ID: 117)
Most Active Art Unit | 2815 |
Art Unit(s) | 2815 |
Total Applications | 416 |
Issued Applications | 363 |
Pending Applications | 8 |
Abandoned Applications | 45 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 10049734
[patent_doc_number] => 09089589
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-28
[patent_title] => 'Micro-RNAs modulating immunity and inflammation'
[patent_app_type] => utility
[patent_app_number] => 13/772035
[patent_app_country] => US
[patent_app_date] => 2013-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 32
[patent_no_of_words] => 17232
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13772035
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/772035 | Micro-RNAs modulating immunity and inflammation | Feb 19, 2013 | Issued |
Array
(
[id] => 10452304
[patent_doc_number] => 20150337318
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-26
[patent_title] => 'RNA TARGETED TO C-MET'
[patent_app_type] => utility
[patent_app_number] => 14/760010
[patent_app_country] => US
[patent_app_date] => 2013-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12591
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14760010
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/760010 | RNA TARGETED TO C-MET | Feb 18, 2013 | Abandoned |
Array
(
[id] => 11813845
[patent_doc_number] => 09717778
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-01
[patent_title] => 'Combination therapy'
[patent_app_type] => utility
[patent_app_number] => 14/376390
[patent_app_country] => US
[patent_app_date] => 2013-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23251
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 162
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14376390
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/376390 | Combination therapy | Feb 3, 2013 | Issued |
Array
(
[id] => 8951284
[patent_doc_number] => 20130197065
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-01
[patent_title] => 'Modulators of Coagulation Factors'
[patent_app_type] => utility
[patent_app_number] => 13/751623
[patent_app_country] => US
[patent_app_date] => 2013-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 23634
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13751623
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/751623 | Modulators of coagulation factors | Jan 27, 2013 | Issued |
Array
(
[id] => 9068696
[patent_doc_number] => 20130260453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-03
[patent_title] => 'METHOD FOR EXPRESSION OF SMALL RNA MOLECULES WITHIN A CELL'
[patent_app_type] => utility
[patent_app_number] => 13/750903
[patent_app_country] => US
[patent_app_date] => 2013-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11843
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13750903
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/750903 | Method for expression of small RNA molecules within a cell | Jan 24, 2013 | Issued |
Array
(
[id] => 9989377
[patent_doc_number] => 09034577
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-05-19
[patent_title] => 'Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell'
[patent_app_type] => utility
[patent_app_number] => 13/749319
[patent_app_country] => US
[patent_app_date] => 2013-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 32
[patent_no_of_words] => 22131
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13749319
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/749319 | Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell | Jan 23, 2013 | Issued |
Array
(
[id] => 10863949
[patent_doc_number] => 08889647
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-18
[patent_title] => 'Recombinant protein for siRNA delivery and composition comprising the same'
[patent_app_type] => utility
[patent_app_number] => 13/742901
[patent_app_country] => US
[patent_app_date] => 2013-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 6535
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13742901
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/742901 | Recombinant protein for siRNA delivery and composition comprising the same | Jan 15, 2013 | Issued |
Array
(
[id] => 10974717
[patent_doc_number] => 20140377752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-25
[patent_title] => 'NOVEL SYNTHESIS-REGULATING SRNA AND METHOD FOR PREPARING SAME'
[patent_app_type] => utility
[patent_app_number] => 14/371557
[patent_app_country] => US
[patent_app_date] => 2013-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 24173
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14371557
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/371557 | Synthesis-regulating sRNA and method for preparing same | Jan 10, 2013 | Issued |
Array
(
[id] => 13000403
[patent_doc_number] => 10023862
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-17
[patent_title] => Organic compositions to treat beta-catenin-related diseases
[patent_app_type] => utility
[patent_app_number] => 14/371131
[patent_app_country] => US
[patent_app_date] => 2013-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 136131
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14371131
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/371131 | Organic compositions to treat beta-catenin-related diseases | Jan 7, 2013 | Issued |
Array
(
[id] => 8841967
[patent_doc_number] => 20130137596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-30
[patent_title] => 'MicroRNA Expression Abnormalities in Pancreatic Endocrine and Acinar Tumors'
[patent_app_type] => utility
[patent_app_number] => 13/727794
[patent_app_country] => US
[patent_app_date] => 2012-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 33653
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13727794
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/727794 | MicroRNA Expression Abnormalities in Pancreatic Endocrine and Acinar Tumors | Dec 26, 2012 | Abandoned |
Array
(
[id] => 11219144
[patent_doc_number] => 09447471
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-09-20
[patent_title] => 'Microrna profiling for diagnosis of dysplastic nevi and melanoma'
[patent_app_type] => utility
[patent_app_number] => 13/728053
[patent_app_country] => US
[patent_app_date] => 2012-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 28985
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13728053
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/728053 | Microrna profiling for diagnosis of dysplastic nevi and melanoma | Dec 26, 2012 | Issued |
Array
(
[id] => 9307035
[patent_doc_number] => 20140045709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-13
[patent_title] => 'MicroRNA Expression Abnormalities in Pancreatic Endocrine and Acinar Tumors'
[patent_app_type] => utility
[patent_app_number] => 13/727785
[patent_app_country] => US
[patent_app_date] => 2012-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 33627
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13727785
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/727785 | MicroRNA Expression Abnormalities in Pancreatic Endocrine and Acinar Tumors | Dec 26, 2012 | Abandoned |
Array
(
[id] => 8891661
[patent_doc_number] => 20130164845
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-27
[patent_title] => 'Compositions and Methods for the Delivery of Biologically Active RNAs'
[patent_app_type] => utility
[patent_app_number] => 13/726337
[patent_app_country] => US
[patent_app_date] => 2012-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 70565
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13726337
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/726337 | Compositions and Methods for the Delivery of Biologically Active RNAs | Dec 23, 2012 | Abandoned |
Array
(
[id] => 8904901
[patent_doc_number] => 20130172404
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-04
[patent_title] => 'Delivery of Oligonucleotide Functionalized Nanoparticles'
[patent_app_type] => utility
[patent_app_number] => 13/721366
[patent_app_country] => US
[patent_app_date] => 2012-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 25166
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13721366
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/721366 | Delivery of oligonucleotide functionalized nanoparticles | Dec 19, 2012 | Issued |
Array
(
[id] => 10414700
[patent_doc_number] => 20150299710
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-22
[patent_title] => 'Inhibitory Oligonucleotide and Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 14/442799
[patent_app_country] => US
[patent_app_date] => 2012-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10203
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14442799
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/442799 | Inhibitory oligonucleotide and use thereof | Nov 28, 2012 | Issued |
Array
(
[id] => 11263522
[patent_doc_number] => 09487809
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-08
[patent_title] => 'Decreasing lactate level and increasing polypeptide production by downregulating the expression of lactate dehydrogenase and pyruvate dehydrogenase kinase'
[patent_app_type] => utility
[patent_app_number] => 13/688075
[patent_app_country] => US
[patent_app_date] => 2012-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 20545
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13688075
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/688075 | Decreasing lactate level and increasing polypeptide production by downregulating the expression of lactate dehydrogenase and pyruvate dehydrogenase kinase | Nov 27, 2012 | Issued |
Array
(
[id] => 9626282
[patent_doc_number] => 08795959
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-08-05
[patent_title] => 'Isolated glucokinase genomic polynucleotide fragments from chromosome 7'
[patent_app_type] => utility
[patent_app_number] => 13/680178
[patent_app_country] => US
[patent_app_date] => 2012-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12918
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 210
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13680178
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/680178 | Isolated glucokinase genomic polynucleotide fragments from chromosome 7 | Nov 18, 2012 | Issued |
Array
(
[id] => 8829206
[patent_doc_number] => 20130130251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-23
[patent_title] => 'IDENTIFICATION OF SNARE YKT6 SEQUENCES'
[patent_app_type] => utility
[patent_app_number] => 13/680203
[patent_app_country] => US
[patent_app_date] => 2012-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12915
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13680203
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/680203 | IDENTIFICATION OF SNARE YKT6 SEQUENCES | Nov 18, 2012 | Abandoned |
Array
(
[id] => 11357576
[patent_doc_number] => 09534220
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-03
[patent_title] => 'Antisense antibacterial method and compound'
[patent_app_type] => utility
[patent_app_number] => 13/680790
[patent_app_country] => US
[patent_app_date] => 2012-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 29
[patent_no_of_words] => 17751
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13680790
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/680790 | Antisense antibacterial method and compound | Nov 18, 2012 | Issued |
Array
(
[id] => 11357576
[patent_doc_number] => 09534220
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-03
[patent_title] => 'Antisense antibacterial method and compound'
[patent_app_type] => utility
[patent_app_number] => 13/680790
[patent_app_country] => US
[patent_app_date] => 2012-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 29
[patent_no_of_words] => 17751
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13680790
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/680790 | Antisense antibacterial method and compound | Nov 18, 2012 | Issued |